Wegovy pill: Where to find Novo Nordisk’s new GLP-1 medication—and how much it costs

For years, pharmaceutical companies have been racing to develop a market-ready GLP-1 weight-loss pill to join the ranks of popular injectables. Today, Novo Nordisk’s oral version of Wegovy is officially available for purchase.

The Wegovy pill, which contains the active ingredient semaglutide, has been in clinical trials for over two years and was approved by the Food and Drug Administration on December 22. It is the first and only oral GLP-1 (glucagon-like peptide-1) medication for weight...